Literature DB >> 7797912

Irreversible effects of ivermectin on adult parasites in onchocerciasis patients in the Onchocerciasis Control Programme in West Africa.

A P Plaisier1, E S Alley, B A Boatin, G J Van Oortmarssen, H Remme, S J De Vlas, L Bonneux, J D Habbema.   

Abstract

Ivermectin is an effective drug for the treatment of human onchocerciasis, a disease caused by the parasitic filarial nematode Onchocerca volvulus. When humans are treated, the microfilariae normally found in the skin are rapidly and very nearly completely eliminated. Nonetheless, after a delay, microfilariae gradually reappear in the skin. This study is concerned with the causes of this delay. Hypotheses are tested by comparing the results of model calculations with skin microfilaria counts collected from 114 patients during a trial of five annual treatments in the focus area of Asubende, Ghana. The results obtained strongly suggest that annual treatment with ivermectin causes an irreversible decline in microfilariae production of approximately 30%/treatment. This result has important implications for public health strategies designed to eliminate onchocerciasis as a significant health hazard.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7797912     DOI: 10.1093/infdis/172.1.204

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  45 in total

1.  Modeling targeted ivermectin treatment for controlling river blindness.

Authors:  Eric M Poolman; Alison P Galvani
Journal:  Am J Trop Med Hyg       Date:  2006-11       Impact factor: 2.345

2.  Identifying sub-optimal responses to ivermectin in the treatment of River Blindness.

Authors:  Thomas S Churcher; Sébastien D S Pion; Mike Y Osei-Atweneboana; Roger K Prichard; Kwablah Awadzi; Michel Boussinesq; Richard C Collins; James A Whitworth; María-Gloria Basáñez
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-17       Impact factor: 11.205

3.  Required duration of combined annual ivermectin treatment and vector control in the Onchocerciasis Control Programme in west Africa.

Authors:  A P Plaisier; E S Alley; G J van Oortmarssen; B A Boatin; J D Habbema
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

4.  Nodding syndrome in Mundri county, South Sudan: environmental, nutritional and infectious factors.

Authors:  P S Spencer; K Vandemaele; M Richer; V S Palmer; S Chungong; M Anker; Y Ayana; M L Opoka; B N Klaucke; A Quarello; J K Tumwine
Journal:  Afr Health Sci       Date:  2013-06       Impact factor: 0.927

5.  Genotypic analysis of β-tubulin in Onchocerca volvulus from communities and individuals showing poor parasitological response to ivermectin treatment.

Authors:  Mike Y Osei-Atweneboana; Daniel A Boakye; Kwablah Awadzi; John O Gyapong; Roger K Prichard
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-02-12       Impact factor: 4.077

6.  Feasibility of Onchocerciasis Elimination Using a "Test-and-not-treat" Strategy in Loa loa Co-endemic Areas.

Authors:  David J Blok; Joseph Kamgno; Sebastien D Pion; Hugues C Nana-Djeunga; Yannick Niamsi-Emalio; Cedric B Chesnais; Charles D Mackenzie; Amy D Klion; Daniel A Fletcher; Thomas B Nutman; Sake J de Vlas; Michel Boussinesq; Wilma A Stolk
Journal:  Clin Infect Dis       Date:  2021-06-15       Impact factor: 9.079

7.  Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal.

Authors:  Lamine Diawara; Mamadou O Traoré; Alioune Badji; Yiriba Bissan; Konimba Doumbia; Soula F Goita; Lassana Konaté; Kalifa Mounkoro; Moussa D Sarr; Amadou F Seck; Laurent Toé; Seyni Tourée; Jan H F Remme
Journal:  PLoS Negl Trop Dis       Date:  2009-07-21

8.  How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment?

Authors:  Natalie V S Vinkeles Melchers; Wilma A Stolk; Michele E Murdoch; Belén Pedrique; Marielle Kloek; Roel Bakker; Sake J de Vlas; Luc E Coffeng
Journal:  PLoS Negl Trop Dis       Date:  2021-06-11

9.  Uncertainty surrounding projections of the long-term impact of ivermectin treatment on human onchocerciasis.

Authors:  Hugo C Turner; Thomas S Churcher; Martin Walker; Mike Y Osei-Atweneboana; Roger K Prichard; María-Gloria Basáñez
Journal:  PLoS Negl Trop Dis       Date:  2013-04-25

10.  Dynamics of Onchocerca volvulus microfilarial densities after ivermectin treatment in an ivermectin-naïve and a multiply treated population from Cameroon.

Authors:  Sébastien D S Pion; Hugues C Nana-Djeunga; Joseph Kamgno; Nicholas Tendongfor; Samuel Wanji; Flobert Njiokou; Roger K Prichard; Michel Boussinesq
Journal:  PLoS Negl Trop Dis       Date:  2013-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.